Pimavanserin and Aggression and Social Cognition.
Pimavanserin and Aggression and Social Cognition.
Recruiting · NCT05895513 · Registry updated 2025-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pimavanserin and Aggression and Social Cognition. | Disruptive, Impulse Control, and Conduct Disorders, intermittent explosive disorder, psychiatric disorder | Recruiting | Phase 2 | 2025-03-27 | NCT05895513 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ACADIA Pharmaceuticals Inc. | 9 |
| Ohio State University | 297 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Ohio State University College of Medicine | Columbus | United States | 4 |